Real World Evidence Strategy Lead (Rare diseases)

Apply now

Date: Jul 11, 2019

Location: 0, BE

Real World Evidence – Strategy Lead (Rare Diseases)


Location: Brussels, Slough, Monheim, or Raleigh


At UCB, we believe that one day Real-World Data (RWD) will be the most influential source of evidence in healthcare, ensuring every patient gets the right care. Will you join us in our pioneering adventure?

We are looking to fill the position of Real-World Evidence (RWE) Strategy Lead for rare diseases, to support our pipeline of innovative medicines in new patient populations. You will join our growing global RWE Practice of epidemiologists, analysts, methodologists and health outcomes experts, a team which is accountable for all global RWE activities undertaken at UCB. The position will be based in one of our global locations (Brussels, Belgium; Slough, UK; Monheim, Germany; or Raleigh, USA).


Job summary

The primary goal of the RWE Strategy Lead for Rare Diseases is to provide leadership and subject matter expertise in RWE generation for rare diseases across the portfolio. Your remit will include multiple assets and disease areas, ranging from evidence generation to ensure successful Phase 3 and launch of late-stage programs, to supporting earlier stage assets and discovery research. As such, this role provides a fantastic opportunity to shape UCB’s overall approach to rare diseases and patient subpopulations, to apply established and novel RWE generation methods, and ultimately, to impact the probability that our innovative medicines reach the right patients.

More broadly, you will help ensure a flawless connection between the RWE Practice and relevant Patient Solution Teams (PSTs) and/or Patient Value Units (PVUs) in delivering and demonstrating the value of our pipeline. Your contributions will advance UCB’s deeper understanding of disease and the real-life experiences of patients, in order to:

  • drive strategic internal decision-making that empowers differentiating R&D activities, successful product launches, and impactful post-marketing activities;
  • support external decision-making by key stakeholder groups such as policy makers, payers, and prescribers;
  • contribute to the wider medical understanding of diseases/indications and their burden;
  • guide clinical development decisions concerning the selection of appropriate clinical/patient-relevant endpoints, treatment comparators, target patients segments; and
  • support key components of UCB’s patient value strategy through the exploration of new perspectives that can augment ‘traditional’ clinical data, thereby driving emerging opportunities designed to reduce the time to patient access to new medicines.


Major accountabilities

You will help ensure the success of UCB’s approach to rare diseases and patient subpopulations by:

  • Acting as a single point of contact for RWE expertise in rare diseases and patient subpopulations, liaising with other RWE Strategy Leads (across the 4 major PVUs) and the wider RWE community to educate and “raise the bar” in the proactive identification and prioritization of RWE needs and opportunities;
  • Co-creating applicable global RWE Strategy & Tactical Plan(s);
  • Assuming accountability for the execution of applicable global RWE studies, plus the delivery, interpretation and communication of findings;
  • Designing study concepts, and working with the relevant RWE Lead Scientists, Scientists, Methodologists and Analysts to translate these into study protocols;
  • Membership of relevant teams, including (as required): PST subteams and PVU missions, Benefit-Risk Teams, Strategic Publications Planning, and applicable leadership teams;
  • Helping to shape the use and acceptance of RWE in the external environment through collaborations with relevant colleagues in policy and external engagement at UCB.   


Interested? For this position you’ll need the following education, experience and skills:

Minimally required experience: This position requires specific proven experience in supporting the development and execution of RWE strategy and tactics for rare disease therapeutics. You will have at least 5 years’ experience successfully delivering global and/or local RWE projects from conceptualization to publication within the pharmaceutical industry or with a recognized expert consultancy (eg, studies using large healthcare databases; studies assessing effectiveness, safety and resource-utilization outcomes; post-marketing commitments or disease registries). You will have good knowledge of industry trends, best practices, and external stakeholders expectations of RWE, specifically related to epidemiology/outcomes research, regulatory affairs, patient safety and market access. You have a proven track record supporting multiple assets and therapeutic areas simultaneously, plus people- or project-management experience in cross-functional teams or matrix organizations. You have a high-calibre publication record in relevant peer-reviewed journals.   

Desirable/preferred experience: experience supporting pipeline assets through confirmatory development (ie, phase 3 or pivotal phase 2) to launch; experience with autoimmune or neurological noncommunicable rare diseases. Depth and breadth of experience will be reflected in the grade.



Technical Expertise/Skills

  • Good background knowledge of industry trends and best practices, specifically related to epidemiology/outcomes research
  • Good knowledge and understanding of applicable regulations in pharmacovigilance and clinical development
  • Ability to solve scientific and technical questions/problems related to the epidemiology and pharmacovigilance environment
  • Expertise in the EU5/ US healthcare environment (and changes therein)
  • Ability to leverage changes in the EU5/US healthcare system and other healthcare systems to help plan and drive development of appropriate, innovative and mutually beneficial patient access plans and solutions in support of UCB compounds providing value to institutional/individual stakeholders including regulators and payers in addition to patients and physicians
  • Thorough understanding of pharmaceutical business models and cultural drivers


    Problem solving

  • Able to think strategically and tactically “out of the box” with the “big picture” in mind
  • Ability to work in cross-functional / cross-cultural / multinational teams to generate "buy-in" and align stakeholders on decisions while generating enthusiasm for the agreed path forward
  • Able to work successfully with other SMEs such as PAP, GRA, etc., affiliate colleagues, PVU access leads and other PVU stakeholders, vendors, consultants and academics across different countries
  • High levels of initiative, drive and commitment
  • Ability to prioritize among large, volumes of diverse projects and activities



  • Excellent and effective oral/written skills in English
  • Proven ability to write/edit scientific communications (abstracts, poster presentations, podium presentations, manuscripts, etc.)
  • Able to deliver presentations or reports to senior management or industry audiences with a relaxed and proficient presentation style



  • Clear focus on patient-centricity
  • Succeeded in maintaining good collaboration with key partners and stakeholders
  • Experience working with multidisciplinary cross functional and cross-cultural project teams
  • Ability to proactively use his/her relationships with internal and external stakeholder groups to synthesize thinking, build advocacy and empower implementation of the solutions in support of UCB portfolio performance and patient outcome
  • Drive for innovation and creativity
  • Visionary, strategic and tactical capabilities
  • Strong understanding of international and cultural differences
  • Able to analyse rapidly and assimilate facts quickly
  • People and process driven
  • Highly committed to quality and constantly seeking to improve it
  • Ability to act as an ambassador for patients and UCB
  • Demonstrated professional maturity in stressful situations or conflicts 



  • Manage timelines and projects (project planning)
  • Deliver objectives in line with corporate and product targets
  • Well organized, structured, with a logic approach to issues raised


UCB is a global biopharmaceutical company. We focus on discovering and developing innovative medicines and lateral solutions that can transform the everyday lives of people with severe diseases of the immune system – or the central nervous system.

With more than 8500 people in approximately 40 countries, UCB offers an exciting working environment where initiative can flourish and those with a ‘can-do’ attitude can thrive.  Scientific excellence, innovation, co-creation, lateral thinking, reinventing the way we do things…these are some of the key competencies we are constantly developing, and looking for, at UCB.

Job Segment: Epidemiology, Neurology, Public Health, Medical, Pharmacovigilance, Healthcare

Apply now